TY - BOOK
T1 - Virus-like particles in vaccine development
AU - Buonaguro, Franco M.
AU - Buonaguro, Luigi
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.
AB - Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.
UR - http://www.scopus.com/inward/record.url?scp=84956818063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84956818063&partnerID=8YFLogxK
U2 - 10.2217/9781780844176
DO - 10.2217/9781780844176
M3 - Book
AN - SCOPUS:84956818063
SN - 9781780844176
SN - 9781780844190
BT - Virus-like particles in vaccine development
PB - Future Medicine Ltd.
ER -